The growing family of hereditary renal cell carcinoma

Nephrology Dialysis Transplantation

Volumn 19, Issue 12, 2004, Pages 2954-2958

  Richard, Stéphane ^a,b   Lidereau, Rosette ^c   Giraud, Sophie ^a,d  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CENTRE RENÉ HUGUENIN   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Birt Hogg Dub (BHD); Chromosome 3 translocations; Fumarate hydratase; Hereditary renal cell carcinoma; MET proto oncogene; von Hippel Lindau (VHL)

Indexed keywords

HAMARTIN; SCATTER FACTOR RECEPTOR; SUCCINATE DEHYDROGENASE; TUBERIN; TUMOR SUPPRESSOR PROTEIN; VON HIPPEL LINDAU PROTEIN;

AUTOSOMAL DOMINANT INHERITANCE; BIRT HOGG DUBE SYNDROME; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 3P; CHROMOSOME 9Q; CHROMOSOME TRANSLOCATION 3; CIGARETTE SMOKING; CLEAR CELL CARCINOMA; CLINICAL FEATURE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EDITORIAL; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPERPARATHYROIDISM; JAW TUMOR; KIDNEY CARCINOMA; KIDNEY SURGERY; LEIOMYOMATOSIS; METASTASIS POTENTIAL; NEPHRECTOMY; OBESITY; OCCUPATIONAL EXPOSURE; PARAGANGLIOMA; PRIORITY JOURNAL; RISK FACTOR; THYROID PAPILLARY CARCINOMA; TUBEROUS SCLEROSIS; UROGRAPHY; VON HIPPEL LINDAU DISEASE;

EID: 11244354864     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh535     Document Type: Editorial

References (40)

1. Godley P, Kim SW. Renal cell carcinoma. Curr Opin Oncol 2002; 14: 280-285
2. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal tumors. J Pathol 1997; 183: 131-133
3. Pavlovich CP, Schmidt LS. Searching for the hereditary causes of renal-cell carcinoma. Nature Rev Cancer 2004; 4: 381-393
4. Zbar B, Klausner R, Linehan WM. Studying cancer families to identify kidney cancer genes. Annu Rev Med 2003; 54: 217-233
5. Zimmer M, Iliopoulos O. Molecular genetics of kidney cancer. Cancer Treat Res 2003; 116: 3-27
6. Richard S, Graff J, Lindau J, Resche F. Von Hippel-Lindau disease. Lancet 2004; 363: 1231-1234
7. Lonser RR, Glenn G, Walther McC et al. Von-Hippel-Lindau disease. Lancet 2003; 361: 2059-2067
8. Chauveau D, Duvic C, Chrétien Y et al. Renal involvement in von Hippel-Lindau disease. Kidney Int 1996; 50: 944-951
9. Latif F, Tory K, Gnarra J et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260: 1317-1320
10. Kaelin WG Jr. Molecular basis of the VHL hereditary cancer syndrome. Nature Rev Cancer 2002; 2: 673-682
11. Maxwell PH, Wiesener MS, Chang GW et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-275
12. Ang SO, Chen H, Hirota K et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nature Genet 2002; 32: 614-621
13. Gnarra J, Tory K, Weng Y et al. Mutations of the VHL tumour suppressor gene in renal carcinomas. Nature Genet 1994; 7: 85-90
14. Cohen AJ, Li FP, Berg S et al. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 1979; 301: 592-595
15. Bodmer D, van den Hurk W, van Groningen JJ et al. Understanding familial and non-familial renal cell cancer. Hum Mol Genet 2002; 11: 2489-2498
16. Bodmer D, Schepens M, Eleveld MJ, Schoemnakers EF, Geurts van Kessel A. Disruption of a novel gene, DIRC3, and expression of DIRC3-HSPBAP1 fusion transcripts in a case of familial renal cell cancer and t(2;3)(q35;q21). Genes Chromosomes Cancer 2003; 38: 107-116
17. Chen J, Lui WO, Vos MD et al. The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. Cancer Cell 2003; 4: 405-413
18. Teh BT, Giraud S, Sari NF et al. Familial non-VHL non-papillary clear-cell renal cancer. Lancet 1997; 349: 848-849
19. Woodward ER, Clifford SC, Astuti D, Affara NA, Maher ER. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes. J Med Genet 2000; 37: 348-353.
20. Vanharanta S, Buchta M, McWhinney SR et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 2004; 74: 153-159
21. Lendvay TS, Marshall FF. The tuberous sclerosis complex and its highly variable manifestations. J Urol 2003; 169: 1635-1642
22. Schmidt L, Duh FM, Chen F et al. Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nature Genet 1997; 16: 68-73
23. Zhuang Z, Park WS, Pack S et al. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nature Genet 1998; 20: 66-69
24. Tomlinson IP, Alam NA, Rowan AJ et al. Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nature Genet 2002; 30: 406-410
25. Alam NA, Rowan AJ, Wortham NC et al. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 2003; 12: 1241-1252
26. Carpten JD, Robbins CM, Villablanca A et al. HPRT2 encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nature Genet 2002; 32: 676-680
27. Malchoff CD, Sarfarazi M, Tendler B et al. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 2000; 85: 1758-1764
28. Nickerson ML, Warren MB, Toro JR et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell 2002; 2: 157-164
29. Khoo SK, Giraud S, Kahnoski K et al. Clinical and genetic study of Birt-Hogg Dubé syndrome. J Med Genet 2002; 39: 906-912
30. Khoo SK, Kalmoski K, Sugimura J et al. Inactivation of BHD in sporadic renal tumors. Cancer Res 2003; 63: 4583-4587
31. Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM. Hereditary renal cancers. Radiology 2003; 226: 33-46
32. Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke P, Walther McM. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 2001; 165: 777-781
33. Pavlovich CP, Walther McCM, Choyke PL et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002; 167: 10-15
34. Shingleton WB, Sewell PE Jr. Percutaneous renal cryoablation of renal tumors in patients with von Hippel-Lindau disease. J Urol 2002; 167: 1268-1270
35. Madhusudan S, Deplanque G, Braybrooke JP et al. Antiangiogenic therapy for von Hippel-Lindau disease. J Am Med Assoc 2004; 291: 943-944
36. Yang JC, Haworth L, Sherry RM et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 2003; 349: 427-434
37. Sattler M, Pride YB, Ma P et al. A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase. Cancer Res 2003; 63: 5462-5469
38. Ma W, Tessarollo L, Hong SB et al. Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. Cancer Res 2003; 63: 5320-5328
39. Okimoto A, Sakurai J, Kobayashi T et al. A germline in the Birt-Hogg-Dubé (BHD) gene gives rise to the Nihon rat model of inherited renal cancer. Proc Natl Acad Sci USA 2004; 101: 2023-2027
40. Lingaas F, Comstock KE, Kirkness EF et al. A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinomas and nodular dermatofibrosis in the German shepherd dog. Hum Mol Genet 2003; 12: 3043-3053